Clinical Trial Update: Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous bone marrow-derived stem cell transplantation for retinitis pigmentosa has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Autologous bone marrow-derived stem cells transplantation

Snippet

Sponsor: University of Sao Paulo | Conditions: Retinitis Pigmentosa | Phase 1 | Status: COMPLETED